These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2692427)

  • 41. Immunization trials with the ring-infected erythrocyte surface antigen of Plasmodium falciparum in owl monkeys (Aotus vociferans).
    Collins WE; Pappaioanou M; Anders RF; Campbell GH; Brown GV; Kemp DJ; Broderson JR; Coppel RL; Skinner JC; Procell PM
    Am J Trop Med Hyg; 1988 Mar; 38(2):268-82. PubMed ID: 3281493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasmodium falciparum: administration of anti-sporozoite antibodies during sporogony results in production of sporozoites which are not neutralized by human anti-circumsporozoite protein vaccine sera.
    do Rosario VE; Appiah A; Vaughan JA; Hollingdale MR
    Trans R Soc Trop Med Hyg; 1989; 83(3):305-7. PubMed ID: 2694460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccines for human malaria: epidemiological and immunological perspectives.
    Webster HK; Diggs CL; Ballou WR; Chulay JD
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):375-89. PubMed ID: 3064321
    [No Abstract]   [Full Text] [Related]  

  • 44. Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice.
    Playfair JH; De Souza JB
    Clin Exp Immunol; 1987 Jan; 67(1):5-10. PubMed ID: 3113784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier.
    Lise LD; Mazier D; Jolivet M; Audibert F; Chedid L; Schlesinger D
    Infect Immun; 1987 Nov; 55(11):2658-61. PubMed ID: 2444539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
    J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate.
    Giersing B; Miura K; Shimp R; Wang J; Zhou H; Orcutt A; Stowers A; Saul A; Miller LH; Long C; Singh S
    Infect Immun; 2005 Jul; 73(7):3963-70. PubMed ID: 15972483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum.
    Sharma P; Ruebush TK; Campbell GH; Richman SJ; Wilkins PP; Broderson JR; Ardeshir F; Gross M; Silverman C; Skinner JC
    Am J Trop Med Hyg; 1992 Jun; 46(6):691-707. PubMed ID: 1621894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.
    Patarroyo ME; Amador R; Clavijo P; Moreno A; Guzman F; Romero P; Tascon R; Franco A; Murillo LA; Ponton G
    Nature; 1988 Mar; 332(6160):158-61. PubMed ID: 2450281
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficiency of human Plasmodium falciparum malaria vaccine candidates in Aotus lemurinus monkeys.
    Herrera S; Herrera MA; Certa U; Corredor A; Guerrero R
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():423-8. PubMed ID: 1343722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine.
    Good MF; Berzofsky JA; Maloy WL; Hayashi Y; Fujii N; Hockmeyer WT; Miller LH
    J Exp Med; 1986 Aug; 164(2):655-60. PubMed ID: 2425037
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immunologic prevention of malaria].
    Wagner WH
    Med Monatsschr Pharm; 1990 Jul; 13(7):209-15. PubMed ID: 1695990
    [No Abstract]   [Full Text] [Related]  

  • 53. TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses.
    Fox CB; Moutaftsi M; Vergara J; Desbien AL; Nana GI; Vedvick TS; Coler RN; Reed SG
    Vaccine; 2013 Dec; 31(49):5848-55. PubMed ID: 24120675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display.
    Singh SK; Thrane S; Janitzek CM; Nielsen MA; Theander TG; Theisen M; Salanti A; Sander AF
    Vaccine; 2017 Jun; 35(30):3726-3732. PubMed ID: 28578824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei.
    Romero PJ; Tam JP; Schlesinger D; Clavijo P; Gibson H; Barr PJ; Nussenzweig RS; Nussenzweig V; Zavala F
    Eur J Immunol; 1988 Dec; 18(12):1951-7. PubMed ID: 2464495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [NANP]19-5.1. A malaria vaccine field trial in Nigerian children.
    Reber-Liske R; Salako LA; Matile H; Sowunmi A; Stürchler D
    Trop Geogr Med; 1995; 47(2):61-3. PubMed ID: 8592764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proteosome-lipopeptide vaccines: enhancement of immunogenicity for malaria CS peptides.
    Lowell GH; Ballou WR; Smith LF; Wirtz RA; Zollinger WD; Hockmeyer WT
    Science; 1988 May; 240(4853):800-2. PubMed ID: 2452484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sporozoite malaria vaccine. Where do we stand?
    Nussenzweig V; Nussenzweig S
    Ann Parasitol Hum Comp; 1990; 65 Suppl 1():49-52. PubMed ID: 1702271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclophosphamide potentiates the antitumor activity of v-p97NY.
    Estin CD; Stevenson US; Hellström I; Hellström KE
    Cell Immunol; 1989 Apr; 120(1):126-31. PubMed ID: 2702696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin 1 and its synthetic peptides as adjuvants for poorly immunogenic vaccines.
    Antoni G; Presentini R; Perin F; Nencioni L; Villa L; Censini S; Ghiara P; Volpini G; Bossu' P; Tagliabue A
    Adv Exp Med Biol; 1989; 251():153-60. PubMed ID: 2692425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.